Plasma membrane domain organization regulates EGFR signaling in tumor cells

Patrick Lajoie1, Emily A Partridge, Ginette Guay

  • 1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.

Insights

Competition between galectin lattices and caveolin-1 microdomains regulates epidermal growth factor receptor (EGFR) signaling. Caveolin-1 acts as a tumor suppressor when N-glycans are insufficient for galectin lattice formation.

Area of Science:

  • Cell biology
  • Molecular biology
  • Cancer research

Background:

  • Macromolecular complexes in plasma membranes have reduced diffusion, but their physiological impact is unclear.
  • Plasma membrane organization influences receptor signaling dynamics.

Purpose of the Study:

  • To investigate how competition between galectin lattices and caveolin-1 microdomains for epidermal growth factor receptor (EGFR) recruitment affects EGFR signaling in tumor cells.
  • To elucidate the role of Golgi beta1,6N-acetylglucosaminyltransferase V (Mgat5) in regulating this interaction and its impact on tumor growth.

Main Methods:

  • Studied EGFR recruitment dynamics in mammary tumor cells with varying Mgat5 expression.
  • Investigated the effects of galectin lattice formation and caveolin-1 microdomain association on EGFR diffusion and signaling.
  • Utilized caveolin-1 depletion and genetic manipulation of Mgat5.

Main Results:

  • In Mgat5-deficient cells, reduced galectin lattice binding allows increased association with caveolin-1 microdomains, suppressing EGFR signaling.
  • Caveolin-1 depletion enhances EGFR diffusion and EGF responsiveness, alleviating Mgat5 deficiency-related growth restrictions.
  • In Mgat5-expressing cells, EGFR associates with the galectin lattice, reducing diffusion and promoting actin interaction, opposing caveolin-1 sequestration.

Conclusions:

  • Caveolin-1 functions as a conditional tumor suppressor, beneficial when beta1,6GlcNAc-branched N-glycans are below a threshold for galectin lattice formation.
  • The balance between galectin lattice and caveolin-1 microdomains dictates EGFR signaling and diffusion, impacting tumor cell behavior.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...